MDA 19 is a selective agonist of the human peripheral cannabinoid CB2 receptor, with an EC50 for activation (63.4 nM) that is 14-fold lower than that for CB1 activation (EC50 = 867 nM). Surprisingly, it acts as an inverse agonist at the rat CB2 receptor in cell-based functional assays.
1. Diaz, P., et al. 2008. J. Med. Chem. 51: 4932-4947. PMID: 18666769
2. Xu, J.J., et al. 2010. Anesth. Analg. 111: 99-109. PMID: 20522703
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.